Buy & Sell Allakos Inc (ALLK) – Allakos Inc Price Today
Key Stats
- $29.74MMarket Cap
- HealthSector
- -3M Drawdown
- -$46.92MEnterprise Value
- -Dividend Yield
- 37 daysTypical Hold Time
Allakos Inc (ALLK) is currently valued at a market capitalization of $29.74M, with an enterprise value of -$46.92M. Over the past 52 weeks, Allakos Inc has traded between a low of $0.22 and a high of $1.5, highlighting its annual price range. Over the past three months, Allakos Inc has recorded a drawdown of -, reflecting recent price volatility. Allakos Inc offers a dividend yield of -. On average, investors hold Allakos Inc for approximately 37 days, indicating typical investor behavior on the platform.
About Allakos Inc
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells.
